SLRA Presentation & Dinner – September 2016

St. Louis Rheumatology Association

Wednesday, September 22nd 2016

Update on the Treatment and Clinical Research in PAH

Dr. Aryeh Fischer, M.D. is theAssociate Professor of Medicine, Division of Rheumatology and Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado School of Medicine.

His specific area of clinical and research expertise is within systemic sclerosis and autoimmune associated lung diseases, and autoimmune interstitial lung disease in particular. He has developed clinical expertise with patients referred nationally for evaluation of autoimmune lung disease.  Dr. Fischer has served as an invited lecturer on autoimmune and interstitial lung diseases at numerous national and international pulmonary and rheumatology conferences and has numerous original research publications, review articles, and textbook chapters dealing with autoimmune interstitial lung disease.

6:00 – 6:30 pm Registration

6:30 – 9:00 pm Presentation and dinner

Nieman Marcus, Zodiac Room, Hwy 40 and

Lindbergh

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine, Continuing Medical Education and St. Louis Rheumatology Association.  Washington University is accredited by the ACCME to provide continuing medical education for physicians.  Washington University designates this live activity for a maximum of _1_ AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities.  All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations.  Any potential conflicts were addressed and resolved.

 All members of the CME department have nothing to disclose.  Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations. Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients.  All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.

These presentations are not an endorsement of any commercial interests. These presentations are the views and experiences of the presenters.  The presenters’ views do not represent the policy or position of Washington University School of Medicine.  Washington University School of Medicine, Continuing Medical Education, is the sponsor for CME credits.